Systemic Levels of IL-23 are Strongly Associated with Disease Activity in Rheumatoid Arthritis but not Spondyloarthritis

被引：0
|
作者：
Melis, Lode [1 ]
Vandooren, Bernard [1 ]
Kruithof, Elli [1 ]
Jacques, Peggy [1 ]
De Vos, Martine [1 ]
Mielants, Herman [1 ]
Verbrugen, Gust [1 ]
De Keyser, Filip [1 ]
Elewaut, Dirk [1 ]
机构：
[1] Ghent Univ Hosp, B-9000 Ghent, Belgium
来源：
CLINICAL IMMUNOLOGY | 2009年 / 131卷
关键词：
D O I：
10.1016/j.clim.2009.03.139
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [31] Serum IL-6 and IL-23 Levels and Their Correlation with Angiogenic Cytokines and Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome
    Przepiera-Bedzak, Hanna
    Fischer, Katarzyna
    Brzosko, Marek
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [32] Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
    Ellen M. Gravallese
    Georg Schett
    Nature Reviews Rheumatology, 2018, 14 : 631 - 640
  • [33] The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
    Tsukazaki, Hiroyuki
    Kaito, Takashi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 19
  • [34] VITAMIN D, IL-10, IL-17, AND IL-23 AS BIOMARKER FOR DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Senturk, T.
    Cetin, B. G.
    Sargin, G.
    Aydin, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S73 - S73
  • [35] VITAMIN D, IL-10, IL-17, AND IL-23 AS BIOMARKER FOR DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Senturk, T.
    Cetin, B. Genc
    Sargin, G.
    Aydin, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1081 - 1082
  • [36] The IL-23/Th 17 pathway in spondyloarthritis: The Royal Road?
    Wendling, Daniel
    Guillot, Xavier
    Prati, Clement
    JOINT BONE SPINE, 2015, 82 (01) : 1 - 4
  • [37] Impact of IL12B Polymorphisms on Genetic Susceptibility and IL-12p40 and IL-23 Serum Levels in Rheumatoid Arthritis
    Manolova, Irena
    Ivanova, Mariana
    Vasilev, Georgi
    Stoilov, Rumen
    Miteva, Lyuba
    Stanilova, Spaska
    IMMUNOLOGICAL INVESTIGATIONS, 2020, 49 (1-2) : 1 - 14
  • [38] SYSTEMIC IL1 LEVELS IN RHEUMATOID-ARTHRITIS
    EASTGATE, JA
    SYMONS, JA
    WOOD, NC
    DIGIOVINE, FS
    DUFF, GW
    LYMPHOKINE RESEARCH, 1988, 7 (03): : 338 - 338
  • [39] IL-23 inhibition for the treatment of psoriatic arthritis
    Mohanakrishnan, Raagav
    Beier, Secia
    Deodhar, Atul
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (01) : 59 - 65
  • [40] IL-23/IL-17 axis in rheumatoid synovium: IL-23 is a determinant of svnovial IL-17 production
    Stamp, Lisa K.
    Easson, Andrea
    Higton, John
    Hessian, Paul A.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S187 - S188
12345